Chima Oluigbo Professor of Neurological Surgery Professor of Pediatrics (Secondary) Professor of Neurology and Rehabilitation Medicine (Third) Office Phone: 202-476-4585 Email: Email Department: Neurological Surgery

Education

• MBBS, College of Medicine, University of Nigeria, 1996

Biography

Chima Oluigbo, M.D., FRCSC, FAANS, is a pediatric neurosurgeon at Children’s National Hospital and Professor of Neurological Surgery, Neurology and Pediatrics at the George Washington University School of Medicine.

He completed his residency in neurological surgery at University Hospitals Birmingham, England and subsequently completed fellowships at the University of Colorado (pediatric neurosurgery) and the Ohio State University (functional and stereotactic neurosurgery). He is board certified by the American Board of Pediatric Neurological Surgery and the Royal College of Physicians and Surgeons of Canada. He is a Fellow of the American Association of Neurological Surgeons (AANS) and an active member of the Congress of Neurological Surgeons (CNS) and the AANS/CNS Section on Pediatric Neurological Surgery.

Dr. Oluigbo cares for children with all types of diseases of the nervous system such as epilepsy, brain and spine tumors, hydrocephalus, craniosynostosis, spina bifida and tethered spinal cord. He specializes in the surgical care of children with epilepsy as well as pediatric functional and restorative neurosurgery. He uses minimally invasive techniques to treat patients with epilepsy. These techniques include the Visualase laser ablation therapy and the ROSA robot assisted epilepsy surgery. He also uses advanced intraoperative magnetic resonance imaging (iMRI) during epilepsy surgery to optimize seizure control outcomes.

Dr. Oluigbo previously led the epilepsy surgery service at the Ohio State University Medical Center where he was actively involved in functional neurosurgery (deep brain stimulation).

His research interests include epilepsy surgery, deep brain stimulation, functional neurological restoration and the development of innovative neuromodulation therapies for the treatment of chronic neurological disorders including epilepsy, movement disorders, neurobehavioral and cognitive disorders, chronic pain and spasticity in children.

Industry Relationships and Collaborations

This faculty member (or a member of their immediate family) has reported a financial interest with the health care related companies listed below. These relations have been reported to the University and, when appropriate, management plans are in place to address potential conflicts.

• None